Omadacycline Noninferior To Standard Of Care For Community-Acquired Bacterial Pneumonia, Acute Bacterial Skin, Skin-Structure Infections.

MedPage Today (2/6, Walker) reports on the results of randomized trials published in the New England Journal of Medicine finding that “omadacycline, a novel antibiotic in the tetracycline class, was non-inferior to standard of care for both community-acqu...